The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism

Kuzin, Maxim and Schoretsanitis, Georgios and Haen, Ekkehard and Dammann, Gerhard and Hiemke, Christoph and Gruender, Gerhard and Paulzen, Michael (2020) The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism. PHARMACOPSYCHIATRY, 53 (2). pp. 65-70. ISSN 0176-3679, 1439-0795

Full text not available from this repository. (Request a copy)

Abstract

Background Polypharmacy including somatic medications such as proton pump inhibitors is a common phenomenon in psychiatric care. The aim of this study was to evaluate the pantoprazole effects on clozapine metabolism. Methods A large therapeutic drug-monitoring database containing plasma concentrations of CLZ was analyzed. The results were stratified into four groups: a non-smoking (n = 250) and a smoking group (n = 326), and two groups co-medicated with pantoprazole: non-smokers ( n = 26) and smokers (n = 29). The analysis was based on the non-parametrical Mann-Whitney U test (M-W-U) with a significance level of 0.05. Results Differences reached statistical significance for pharmacokinetic parameters between CLZ monotherapy and comedication with pantoprazole neither in smokers nor in nonsmokers (p > 0.05 for M-W-U in pairwise comparisons). In patients with clozapine monotherapy, smokers had a higher daily dosage of CLZ compared to non-smokers (mean dosage 363 +/- 181 vs. 291 +/- 145 mg/day, p < 0.001 for M-W-U). Conclusions Adding pantoprazole to an ongoing treatment with clozapine does not alter the metabolism of clozapine to a significant extent.

Item Type: Article
Uncontrolled Keywords: PROTON PUMP INHIBITORS; PLASMA-CONCENTRATIONS; GENETIC-POLYMORPHISM; OMEPRAZOLE; SMOKING; CYTOCHROME-P450; SCHIZOPHRENIA; PERFORMANCE; RISPERIDONE; SERUM; therapeutic drug monitoring; clozapine; pantoprazole; CYP2C19; smokers
Subjects: 600 Technology > 610 Medical sciences Medicine
600 Technology > 615 Pharmacy
Divisions: Medicine > Lehrstuhl für Psychiatrie und Psychotherapie
Chemistry and Pharmacy > Institute of Pharmacy > Pharmacology and Toxicology (Prof. Schlossmann, formerly Prof. Seifert)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 30 Mar 2021 05:42
Last Modified: 30 Mar 2021 05:42
URI: https://pred.uni-regensburg.de/id/eprint/45026

Actions (login required)

View Item View Item